---
schema_version: "secwatch.filing_event.v1"
accession: "0000950103-22-013822"
form_type: "8-K"
ticker: "PGEN"
cik: "0001356090"
company_name: "PRECIGEN, INC."
filed_at: "2022-08-09T23:59:59+00:00"
generated_at: "2026-06-24T01:52:25.769185+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Precigen enters $100M ATM equity offering with Cantor Fitzgerald

## Summary
- Up to $100M of common stock may be sold at-the-market through Cantor Fitzgerald as agent.
- Commission of 3.0% of gross sales price payable to Cantor Fitzgerald.
- Proceeds to fund clinical/preclinical development and for working capital and general corporate purposes.
- Company has no obligation to sell any shares; may suspend or terminate at any time.

## SEC filing metadata
- accession: 0000950103-22-013822
- form_type: 8-K
- ticker: PGEN
- cik: 0001356090
- company_name: PRECIGEN, INC.
- filed_at: 2022-08-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1356090/000095010322013822/0000950103-22-013822-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1356090/000095010322013822/dp178412_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950103-22-013822
- JSON: https://secwatch.observer/filing/0000950103-22-013822.json
- Plain text: https://secwatch.observer/filing/0000950103-22-013822.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.